2024

1. A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death

   Scientific reports, Vol. 14, Núm. 1, pp. 3000

2. A multitrait genetic study of hemostatic factors and hemorrhagic transformation after stroke treatment

   Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 4, pp. 936-950

3. Assessing the role of Chemokine (C–C motif) ligand 14 in AKI: a European consensus meeting

   Renal Failure, Vol. 46, Núm. 1

4. Association of drought conditions and heavy rainfalls with the quality of drinking water in Barcelona (2010–2022)

   Journal of Exposure Science and Environmental Epidemiology, Vol. 34, Núm. 1, pp. 175-183

5. CandeSpartan Study: Candesartan Spanish Response-prediction and Tolerability study in migraine

   Cephalalgia : an international journal of headache, Vol. 44, Núm. 4

6. Clinical practice guideline on the management of vestibular schwannoma

   Acta Otorrinolaringologica Espanola, Vol. 75, Núm. 2, pp. 108-128

7. Combining loop with thiazide diuretics in patients discharged home after a heart failure decompensation: Association with 30-day outcomes

   European Journal of Internal Medicine

8. Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn's Disease (Versus-CD): Data from the ENEIDA Registry

   Journal of Crohn's & colitis, Vol. 18, Núm. 1, pp. 65-74

9. Correction in article by Juzga-Corrales et al. “Characteristics and outcomes of the Spanish registry for pediatric patients with bicuspid aortic valve (REVAB)”, Rev Esp Cardiol. 2023;76:961-969 (Revista Española de Cardiología (English Edition) (2024) 77(4) (358–359), (S1885585724000331), (10.1016/j.rec.2023.12.011))

   Revista Espanola de Cardiologia

10. Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)

    Alimentary Pharmacology and Therapeutics, Vol. 59, Núm. 10, pp. 1248-1259

11. Efficacy and safety of chemotherapy in young patients with advanced gastroesophageal adenocarcinoma: data from the Spanish AGAMENON-SEOM registry

    Gastric Cancer, Vol. 27, Núm. 1, pp. 131-145

12. Embolization of percutaneous left atrial appendage closure devices: timing, management and clinical outcomes

    Cardiovascular Revascularization Medicine

13. Feasibility and Short-Term Outcomes in Liver-First Approach: A Spanish Snapshot Study (the RENACI Project)

    Cancers, Vol. 16, Núm. 9

14. Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial

    Haematologica, Vol. 109, Núm. 2, pp. 543-552

15. Impact of age on the outcomes of Takotsubo syndrome

    Cardiovascular Revascularization Medicine, Vol. 61, pp. 44-51

16. Impact of the COVID-19 Pandemic on Global TAVR Activity: The COVID-TAVI Study

    JACC: Cardiovascular Interventions, Vol. 17, Núm. 3, pp. 374-387

17. Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish Lung Cancer Group GECP

    Clinical and Translational Oncology

18. Older Adult Patients in the Emergency Department: Which Patients should be Selected for a Different Approach?

    Annals of Geriatric Medicine and Research, Vol. 28, Núm. 1, pp. 9-19

19. Outcomes and predictors of left ventricle recovery in patients with severe left ventricular dysfunction undergoing transcatheter aortic valve implantation

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 20, Núm. 8, pp. e487-e495

20. Prognostic Utility of Society for Cardiovascular Angiography and Interventions Shock Stage Approach for Classifying Cardiogenic Shock Severity in Takotsubo Syndrome

    Journal of the American Heart Association, Vol. 13, Núm. 6, pp. e032951